SR ONE CAPITAL MANAGEMENT, LP
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | DSGN | 6.53M | $69.44M |
 | ZBIO | 5.04M | $98.49M |
 | ORIC | 4.51M | $58.48M |
 | SPRY | 4.01M | $32.22M |
 | NKTX | 3.33M | $7.03M |
 | MANE | 2.40M | $151.68M |
Arcellx, Inc. | ACLX | 2.35M | $269.44M |
 | CRSP | 2.04M | $96.98M |
 | ALMS | 1.96M | $43.18M |
 | MLYS | 1.56M | $42.37M |
 | ENGN | 748K | $5.09M |
 | OCS | 641K | $17.04M |
 | ORKA | 430K | $21.11M |
 | RARE | 138K | $2.89M |
Design Therapeutics, Inc.
DSGN
Shares Held
6.53M
Value
$69.44M
Zenas BioPharma, Inc.
ZBIO
Shares Held
5.04M
Value
$98.49M
ORIC Pharmaceuticals, Inc.
ORIC
Shares Held
4.51M
Value
$58.48M
ARS Pharmaceuticals, Inc.
SPRY
Shares Held
4.01M
Value
$32.22M
Nkarta, Inc.
NKTX
Shares Held
3.33M
Value
$7.03M
Veradermics, Incorporated
MANE
Shares Held
2.40M
Value
$151.68M
Arcellx, Inc.
ACLX
Shares Held
2.35M
Value
$269.44M
CRISPR Therapeutics AG
CRSP
Shares Held
2.04M
Value
$96.98M
Alumis Inc. Common Stock
ALMS
Shares Held
1.96M
Value
$43.18M
Mineralys Therapeutics, Inc.
MLYS
Shares Held
1.56M
Value
$42.37M
enGene Holdings Inc.
ENGN
Shares Held
748K
Value
$5.09M
Oculis Holding AG
OCS
Shares Held
641K
Value
$17.04M
Oruka Therapeutics, Inc.
ORKA
Shares Held
430K
Value
$21.11M
Ultragenyx Pharmaceutical Inc.
RARE
Shares Held
138K
Value
$2.89M